ArticleHeliyon2018

Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1H)-one against Ehrlich ascites carcinoma and sarcoma-180.

Dinesh Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.